Publications by authors named "Slobodan M Jankovic"

Claim this Profile
C
Clinical advances in investigational epilepsy treatments.
Slobodan M Janković

Expert Opin Investig Drugs· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No pharmacovigilance signal of intracranial hypertension associated with glycylcyclines: a FAERS-based disproportionality analysis.
Slobodan M Jankovic, Bojana Vujovic, Allison Rebecca Zamora Coronado, Giovanna Mendes Duarte, Beatriz Pontes de Oliveira Tenório

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics and Pharmacodynamics of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.
Slobodan M Janković, Snežana V Janković

Eur J Drug Metab Pharmacokinet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using validated model informed precision dosing for dose adjustment: superior evidence needed for efficacy and safety.
Slobodan M Janković, Nikola Mirković, Dobrivoje Stojadinović, Snežana Lukić

Expert Opin Drug Metab Toxicol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting.
Svetlana Obrenovic, Marko M Folic, Nevena D Folic, Slobodan M Jankovic

Br J Clin Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonchemotherapy drug-induced cytopenias: A cost-of-illness study using the microcosting methodology based on real-world data.
Ivana Stević, Slobodan M Janković, Nemanja Petrović, Nataša Čanak-Baltić, Valentina Marinković

Br J Clin Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury.
Andrej Belančić, Branislava Raičević, Ivana Stević, Dinko Vitezić, Slobodan M Janković

Pharmacol Res Perspect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventable serious drug-disease interactions of reserve antibiotics.
Slobodan M Janković, Snežana V Janković, Dobrivoje Stojadinović

Expert Opin Drug Metab Toxicol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia-An Inpatient Welfare Institution-Based Cross-Sectional Study.
Aleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, Sara S Mijailovic, Slobodan M Jankovic

Pharmaceuticals (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs.
Branislava B Raičević, Andrej Belančić, Nikola Mirković, Slobodan M Janković

Pharmacol Res Perspect· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature.
Slobodan M Janković, Dobrivoje Stojadinović, Vera Dabanović

Expert Rev Neurother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures.
Miloš Milosavljević, Slobodan M Janković

Expert Opin Drug Saf· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for urinary tract infection and asymptomatic bacteriuria after stroke.
Vladimir S Jankovic, Svetlana D Miletic Drakulic, Slobodan M Jankovic, Snezana R Lazarevic, Sandra M Radevic

J Infect Dev Ctries· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for severe adverse drug reactions in hospitalized patients.
Nemanja Z Petrović, Ana V Pejčić, Miloš N Milosavljević, Slobodan M Janković

Open Med (Wars)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric Data by Using Bioelectrical Analysis as a Parameters for New Classification and Definition of Obesity.
Nizama Salihefendic, Muharem Zildzic, Izet Masic, Slobodan M Jankovic

Mater Sociomed· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with potentially inappropriate prescribing in elderly patients with various degrees of chronic kidney disease.
Gorana G Nedin Rankovic, Ana V Pejcic, Dane A Krtinic, Dragana S Stokanovic, Hristina S Trajkovic, Slobodan M Jankovic

Hemodial Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The silent predictors: exploring galectin-3 and Irisin's tale in severe COVID-19.
Valentina N Nikolic, Višeslav Popadic, Slobodan M Jankovic, Nenad Govedarović, Stevan Vujić

BMC Res Notes· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults.
Vladan Lukic, Slobodan M Jankovic, Nemanja Z Petrovic, Slavica Vucinic, Jasmina Jovic Stosic

Expert Opin Drug Metab Toxicol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of tamsulosine in patients with benign prostatic hyperplasia.
Valentina N Nikolic, Slobodan M Jankovic, Maja Vujovic, Srdjan Sterovic, Ljubomir A Dinic

World J Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of meropenem in critically ill patients.
Aleksandar Rančić, Miloš N Milosavljević, Nikola Rosić, Dragan Milovanović, Marko Folić

Open Med (Wars)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions.
Slobodan M Janković, Snežana V Janković

Eur J Drug Metab Pharmacokinet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics.
Slobodan M Janković, Snežana V Janković

Eur J Drug Metab Pharmacokinet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2.
Miloš N Milosavljević, Medo Gutić, Vladimir Janjić, Slađana Veselinović, Milan Djordjić

Open Med (Wars)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study.
Aleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, Jelena M Dimitrijevic, Sara S Mijailovic, Slobodan M Jankovic

Open Med (Wars)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with hematological adverse reactions of drugs authorized via the centralized procedure.
Ivana Stević, Slobodan M Janković, Andrijana Milošević Georgiev, Valentina Marinković, Dragana Lakić

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis